Karydas Daphne sold MLYS
June 17, 2026 · Form 4 insider transaction
Karydas Daphne sold 3,000 shares of Mineralys Therapeutics, Inc. at $25.00 per share, a transaction worth $75.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,000
Price
$25.00
Total value
$75.0K
InsiderKarydas Daphne
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 17, 2026
Filing dateJune 17, 2026
Shares owned after6,200
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 30, 2025.